Parse Biosciences, a pioneer in single cell sequencing, has announced its groundbreaking GigaLab—a transformative lab designed to upscale single cell sequencing capacity to billions of cells annually. The GigaLab is built upon Parse’s innovative Evercode technology, enhancing throughput with expanded automation and a more robust workflow, enabling scientific advancements in cell profiling previously unimaginable. GigaLab’s […]
Parse Biosciences has announced a significant milestone in their funding journey, securing a total of $50 million through a Series C equity raise and a debt facility. This round of financing was led by Soleus Capital and witnessed participation from several new and existing investors such as Bioeconomy Capital, Janus Henderson Investors, Marshall Wace, Sahsen […]
Parse Biosciences, a provider of accessible and scalable single cell sequencing solutions, has announced the launch of CRISPR Detect, a tool that enables single cell pooled CRISPR screens on an unprecedented scale. This solution from the Seattle-based life sciences company marks a significant advancement in understanding gene function at a genome scale by combining individual […]
